A malaria vaccine that is 77 per cent effective in clinical trials has been approved for use in children 3 to 5 years old, the group most vulnerable to dying from the disease
Ghana is the first country to approve highly effective malaria vaccine
New Scientist - 13 Apr 2023 22:36
A malaria vaccine that is 77 per cent effective in clinical trials has been approved for use in children 3 to 5 years old, the group most vulnerable to dying from the disease
Share this Article
Recommended